Presentation is loading. Please wait.

Presentation is loading. Please wait.

Smoking Cessation Medication

Similar presentations


Presentation on theme: "Smoking Cessation Medication"— Presentation transcript:

1 Smoking Cessation Medication
Gholamreza Heydari MD, MPH, PhD Director Tobacco Prevention and Control Research center Shahid Beheshti Medical University

2 Smokers die early Pirie et al Lancet Jan 12;381(9861):133-41

3 Quitting Works

4

5 Nicotine

6 Mesolimbic dopamine pathway
Binds to nACh receptors Increase in dopamine nicotine positive reinforcement

7 Tobacco withdrawal syndrome
Signs & symptoms Duration Prevalence Irritability < 4 weeks 50% Depression 60% Restlessness Poor concentration < 2 weeks Increased appetite > 10 weeks 70% Sleep disturbance < 1 week 25% Urges to smoke > 2 weeks Mouth Ulcers > 4 weeks 40% Constipation >4 weeks 17%

8 Individual and Environment
The quitting process Individual and Environment Smoking Quit Attempt Abstinence Tobacco Control Policies Brief Interventions (e.g. AB+offer of C) Smoking Cessation Treatments Adapted from: Hughes Drug and alcohol dependence (2011):

9 Remaining Quit Treatment Behavioural support Pharmacotherapy
Supportive environment

10 Healthcare Professionals Role
Health care professionals can increase a patient’s odds of quitting with brief advice, medication, and behavioural support 1 Tasks Identifying people who smoke Motivating a quit attempt Refer for treatment and support Supporting ongoing abstinence This slide provides some basic reasons why education and training of HCPs is necessary. For example: Dangers of smoking Effectiveness of HCP intervention on increasing quit odds Common barriers to TDT AVEYARD P. & WEST R (2007) Managing smoking cessation, BMJ, 335,

11 Advice from a Health Professional is the major external trigger
Source: - Smoking Toolkit Study

12 Pharmacological Interventions for Smoking Cessation

13 Nicotine replacement therapy
Binds to nACh receptors Increase in dopamine Nicotine +++ Nicotine +

14 Nicotine Delivery Source: Royal College of Physicians

15 NRT: Long-term (>6 month) quit rates vs. placebo
Pooled 150 studies RR=1.60 (95% CI: ) Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD DOI: / CD pub4.

16 NRT - safety and side-effects
There are no ‘real’ contraindications to NRT Some individual product differences e.g. gum not good for people with dentures No drug interactions The most common side effects are localised e.g. Taste of oral products Hiccups with the mouth spray Skin irritation with patch Facilitator: Hayden

17 Types of NRT Gum Lozenge Microtab Patch Inhaler Spry

18 Bupropion Atypical antidepressant which acts on dopamine and noradrenaline pathways and possibly as a nicotinic antagonist, designed to reduce motivation to smoke by reducing cravings and withdrawal symptoms reducing the rewarding effect of smoking What to say to your patients? Works by alleviating craving and other withdrawal symptoms It’s not a magic cure, but it will make quitting easier

19 Bupropion: Long-term (>6 month) quit rates vs. placebo
Pooled 36 studies RR=1.69 (95% CI: ) Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD DOI: / CD pub3.

20 Safety and side-effects
Nausea (30%) – mostly well tolerated Seizure Facilitator: Hayden

21 Varenicline Varenicline = partial agonist of the 42 nAchR
What to say to patients Varenicline works by reducing craving for cigarettes making quitting smoking a little easier and increases the chances of stopping for good. However it’s no magic cure and effort is still required.

22 Varenicline: Long-term (>6 month) quit rates vs. placebo
Pooled 14 studies RR=2.27 (95% CI ) Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD DOI: / CD pub6.

23 Safety and side-effects
Nausea (30%) – mostly well tolerated Strange dreams and insomnia Facilitator: Hayden

24 Long-term outcomes Source: New Zealand Guidelines for Helping People Stop Smoking

25 National study on smoking cessation, Iran 2014

26 Conclusion Pharmacotherapy is effective but it is not magic
It must use with other supports First line Champix, NRT, Zyban Facilitator: Hayden

27 Thank you Visit our site: www.tpcrc.sbmu.ac.ir Quit line: 27122050-1
Thank you


Download ppt "Smoking Cessation Medication"

Similar presentations


Ads by Google